Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT04451512
Other study ID # 20200615
Secondary ID
Status Active, not recruiting
Phase
First received
Last updated
Start date January 1, 2020
Est. completion date January 31, 2021

Study information

Verified date June 2020
Source Second Affiliated Hospital of Xi'an Jiaotong University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Patients who met the criteria for removal of 10-19mm colorectal polyps using cold snare or hot snare were included in the study, signed by endoscopic treatment written informed consent for surgery, patients with detailed tracking and record the basic information and information related to the operation, postoperative lack of region and edge endoscopic observation carefully no residue, additional excision may be took if necessary,after resection specimen inspection, and in 6 months review colonoscopy, assess whether there is residual or recurrence of polyps.Main outcome: technical success rate (no other auxiliary resection), complete resection rate, secondary outcome: intraoperative and postoperative complications, polypectomy time and related costs, influential factors of incomplete resection.Research significance: The effectiveness, safety and cost-effectiveness of cold and hot snare resection of 10-19mm colorectal polyps were compared, and the influencing factors of incomplete polyps resection were analyzed, so as to provide evidence for the decision on the best method of medium-size polyps resection.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 40
Est. completion date January 31, 2021
Est. primary completion date July 31, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

1. colorectal polyps sized 10= diameter =19 mm;

2. Boston bowel prepare score: 5-9;

3. The patients all signed the informed consent of endoscopic treatment.

Exclusion Criteria:

1. Complicated with inflammatory bowel disease, P-J syndrome or familial polyposis;

2. Complicated with malignant tumors;

3. polyp size is uncertain;

4. Currently taking aspirin, warfarin or other anticoagulants.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
China The second affiliated hospital of xi'an jiaotong university Xi'an Shaanxi

Sponsors (1)

Lead Sponsor Collaborator
Second Affiliated Hospital of Xi'an Jiaotong University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Technical success rate (without other auxiliary resection) 2020.07.31
Primary Complete resection rate 2021.01.31
Secondary Intraoperative and postoperative complications 2021.01.31
Secondary Polypectomy time 2021.01.31
Secondary related costs of treatment 2021.01.31